<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Exp Ther Med</journal-id><journal-id journal-id-type="iso-abbrev">Exp Ther Med</journal-id><journal-id journal-id-type="publisher-id">ETM</journal-id><journal-title-group><journal-title>Experimental and Therapeutic Medicine</journal-title></journal-title-group><issn pub-type="ppub">1792-0981</issn><issn pub-type="epub">1792-1015</issn><publisher><publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25574229</article-id><article-id pub-id-type="pmc">4280954</article-id><article-id pub-id-type="doi">10.3892/etm.2014.2102</article-id><article-id pub-id-type="publisher-id">etm-09-02-0533</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Antioxidative and antiatherogenic effects of flaxseed, α-tocopherol and their combination in diabetic hamsters fed with a high-fat diet</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>HALIGA</surname><given-names>RALUCA ECATERINA</given-names></name></contrib><contrib contrib-type="author"><name><surname>MOCANU</surname><given-names>VERONICA</given-names></name><xref ref-type="corresp" rid="c1-etm-09-02-0533"></xref></contrib><contrib contrib-type="author"><name><surname>BADESCU</surname><given-names>MAGDA</given-names></name></contrib><aff id="af1-etm-09-02-0533">Department of Pathophysiology, Grigore T. Popa University of Medicine and Pharmacy, Iaşi 700115, Romania</aff></contrib-group><author-notes><corresp id="c1-etm-09-02-0533">Correspondence to: Dr Veronica Mocanu, Department of Pathophysiology, Grigore T. Popa University of Medicine and Pharmacy, 16 Universitatii Street, Iaşi 700115, Romania, E-mail: <email>vmocanu@iasi.mednet.ro</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2015</year></pub-date><pub-date pub-type="epub"><day>03</day><month>12</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>03</day><month>12</month><year>2014</year></pub-date><volume>9</volume><issue>2</issue><fpage>533</fpage><lpage>538</lpage><history><date date-type="received"><day>18</day><month>3</month><year>2014</year></date><date date-type="accepted"><day>24</day><month>9</month><year>2014</year></date></history><permissions><copyright-statement>Copyright © 2015, Spandidos Publications</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0"><license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions><abstract><p><offsets xml_i="3054" xml_f="4974" txt_i="11" txt_f="1931">Oxidative stress has previously been shown to play a role in the pathogenesis of diabetes mellitus (DM) and its complications. In the present study, the effects of supplementation with dietary antioxidants, flaxseed and α-tocopherol were investigated in diabetic golden Syrian hamsters fed with a high-fat diet. Thirty-five golden Syrian hamsters were randomly divided into a control group (C) and four diabetic groups (DM, DM + flax, DM + E and DM + Flax + E). The hamsters received four different diets for a 20-week period, as follows: i) Groups C and DM received a high-fat diet (40% energy as fat), deficient in α-linolenic acid (ALA); ii) the DM + Flax group received a high-fat diet enriched with ground flaxseed 15 g/100 g of food, rich in ALA; iii) the DM + E group received a high-fat diet enriched with vitamin E, 40 mg α-tocopherol/100 g of food; and iv) the DM + Flax + E group received a high-fat diet enriched with flaxseed and vitamin E. The results of serum lipid and oxidative stress analysis suggested that the antiatherogenic effect of flaxseed, α-tocopherol and their combination added to a high-fat diet in diabetic hamsters was based primarily on their antioxidative role, demonstrated by decreased serum lipid peroxidation and increased liver glutathione content. Improvements of serum glucose and non-high-density lipoprotein cholesterol (HDL-C) levels were observed and may have contributed to the prevention of diabetic macroangiopathy evidenced in the histopathological examination. The antioxidant effect of flaxseed was similar to that of α-tocopherol in diabetic hamsters fed a high-fat diet and combined supplementation did not appear to bring more benefits than flaxseed alone. Moreover, the high dose of ground flaxseed alone may have a better cardioprotective effect than α-tocopherol in diabetic hamsters by reducing total cholesterol and non-HDL-C levels and increasing HDL-C levels.</offsets></p></abstract><kwd-group><kwd>diabetes mellitus</kwd><kwd>atherosclerosis</kwd><kwd>oxidative stress</kwd><kwd>golden Syrian hamster</kwd><kwd>flaxseed</kwd><kwd>vitamin E</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title><offsets xml_i="5222" xml_f="5234" txt_i="1939" txt_f="1951">Introduction</offsets></title><p><offsets xml_i="5245" xml_f="5465" txt_i="1952" txt_f="2172">Oxidative stress is considered to be significant in the pathogenesis of diabetes-induced cardiovascular disease (CVD), which is associated with an abnormal blood lipid profile, insulin resistance and metabolic syndrome (</offsets><xref rid="b1-etm-09-02-0533" ref-type="bibr"><offsets xml_i="5511" xml_f="5512" txt_i="2172" txt_f="2173">1</offsets></xref><offsets xml_i="5519" xml_f="5670" txt_i="2173" txt_f="2324">). Oxidative stress occurs due to a disturbance of the balance between antioxidant defense mechanisms and the levels of reactive oxygen species (ROS) (</offsets><xref rid="b2-etm-09-02-0533" ref-type="bibr"><offsets xml_i="5716" xml_f="5717" txt_i="2324" txt_f="2325">2</offsets></xref><offsets xml_i="5724" xml_f="5725" txt_i="2325" txt_f="2326">,</offsets><xref rid="b3-etm-09-02-0533" ref-type="bibr"><offsets xml_i="5771" xml_f="5772" txt_i="2326" txt_f="2327">3</offsets></xref><offsets xml_i="5779" xml_f="6050" txt_i="2327" txt_f="2598">). Numerous studies have identified significant alterations in plasma antioxidant vitamins (including vitamins C, E and A), antioxidant enzyme systems [superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px)] and in lipid peroxidation in diabetes (</offsets><xref rid="b4-etm-09-02-0533" ref-type="bibr"><offsets xml_i="6096" xml_f="6097" txt_i="2598" txt_f="2599">4</offsets></xref><offsets xml_i="6104" xml_f="6105" txt_i="2599" txt_f="2600">,</offsets><xref rid="b5-etm-09-02-0533" ref-type="bibr"><offsets xml_i="6151" xml_f="6152" txt_i="2600" txt_f="2601">5</offsets></xref><offsets xml_i="6159" xml_f="6322" txt_i="2601" txt_f="2764">). In chronic diabetes mellitus (DM), the stability and reactive capacity of antioxidants seriously affect the long-term complications caused by oxidative stress (</offsets><xref rid="b6-etm-09-02-0533" ref-type="bibr"><offsets xml_i="6368" xml_f="6369" txt_i="2764" txt_f="2765">6</offsets></xref><offsets xml_i="6376" xml_f="6377" txt_i="2765" txt_f="2766">,</offsets><xref rid="b7-etm-09-02-0533" ref-type="bibr"><offsets xml_i="6423" xml_f="6424" txt_i="2766" txt_f="2767">7</offsets></xref><offsets xml_i="6431" xml_f="6537" txt_i="2767" txt_f="2873">). Antioxidants have been shown to reduce complications in DM by preventing free radical-mediated damage (</offsets><xref rid="b4-etm-09-02-0533" ref-type="bibr"><offsets xml_i="6583" xml_f="6584" txt_i="2873" txt_f="2874">4</offsets></xref><offsets xml_i="6591" xml_f="6592" txt_i="2874" txt_f="2875">,</offsets><xref rid="b8-etm-09-02-0533" ref-type="bibr"><offsets xml_i="6638" xml_f="6639" txt_i="2875" txt_f="2876">8</offsets></xref><offsets xml_i="6646" xml_f="6648" txt_i="2876" txt_f="2878">).</offsets></p><p><offsets xml_i="6655" xml_f="6832" txt_i="2879" txt_f="3056">Dietary supplementation with antioxidants, including vitamins and phenolic compounds obtained from plants, may help to maintain a desirable pro-oxidative/antioxidative balance (</offsets><xref rid="b9-etm-09-02-0533" ref-type="bibr"><offsets xml_i="6878" xml_f="6879" txt_i="3056" txt_f="3057">9</offsets></xref><offsets xml_i="6886" xml_f="6887" txt_i="3057" txt_f="3058">,</offsets><xref rid="b10-etm-09-02-0533" ref-type="bibr"><offsets xml_i="6934" xml_f="6936" txt_i="3058" txt_f="3060">10</offsets></xref><offsets xml_i="6943" xml_f="7117" txt_i="3060" txt_f="3234">). A variety of dietary sources are presently of considerable interest due to their potential health benefits in relation to numerous diseases, including diabetic disorders (</offsets><xref rid="b11-etm-09-02-0533" ref-type="bibr"><offsets xml_i="7164" xml_f="7166" txt_i="3234" txt_f="3236">11</offsets></xref><offsets xml_i="7173" xml_f="7174" txt_i="3236" txt_f="3237">,</offsets><xref rid="b12-etm-09-02-0533" ref-type="bibr"><offsets xml_i="7221" xml_f="7223" txt_i="3237" txt_f="3239">12</offsets></xref><offsets xml_i="7230" xml_f="7269" txt_i="3239" txt_f="3278">). Flaxseed (also known as linseed and </offsets><italic><offsets xml_i="7277" xml_f="7296" txt_i="3278" txt_f="3297">Linum usitatissimum</offsets></italic><offsets xml_i="7305" xml_f="7409" txt_i="3297" txt_f="3401">), an edible oil seed/grain from a traditional arable crop, has been acknowledged as a functional food (</offsets><xref rid="b13-etm-09-02-0533" ref-type="bibr"><offsets xml_i="7456" xml_f="7458" txt_i="3401" txt_f="3403">13</offsets></xref><offsets xml_i="7465" xml_f="7583" txt_i="3403" txt_f="3521">), and is the focus of considerable attention due to its unique nutrient components and its potential to prevent CVD (</offsets><xref rid="b14-etm-09-02-0533" ref-type="bibr"><offsets xml_i="7630" xml_f="7632" txt_i="3521" txt_f="3523">14</offsets></xref><offsets xml_i="7639" xml_f="7846" txt_i="3523" txt_f="3730">). In addition of being one of the richest plant sources of α-linolenic acid (ALA; ~22% of whole flaxseed), flaxseed is an essential source of lignans (in particular, secoisolariciresinol diglucoside, SDG) (</offsets><xref rid="b15-etm-09-02-0533" ref-type="bibr"><offsets xml_i="7893" xml_f="7895" txt_i="3730" txt_f="3732">15</offsets></xref><offsets xml_i="7902" xml_f="8026" txt_i="3732" txt_f="3856">). SDG has demonstrated extreme radical scavenging activity, thereby protecting polyunsaturated fatty acids from oxidation (</offsets><xref rid="b16-etm-09-02-0533" ref-type="bibr"><offsets xml_i="8073" xml_f="8075" txt_i="3856" txt_f="3858">16</offsets></xref><offsets xml_i="8082" xml_f="8083" txt_i="3858" txt_f="3859">–</offsets><xref rid="b18-etm-09-02-0533" ref-type="bibr"><offsets xml_i="8130" xml_f="8132" txt_i="3859" txt_f="3861">18</offsets></xref><offsets xml_i="8139" xml_f="8285" txt_i="3861" txt_f="4007">). Despite the beneficial effects of SDG, flaxseed consumption has been found to significantly reduce α- and γ-tocopherol concentrations in rats (</offsets><xref rid="b19-etm-09-02-0533" ref-type="bibr"><offsets xml_i="8332" xml_f="8334" txt_i="4007" txt_f="4009">19</offsets></xref><offsets xml_i="8341" xml_f="8425" txt_i="4009" txt_f="4093">) and only vitamin E supplementation was able to restore the plasma concentrations (</offsets><xref rid="b20-etm-09-02-0533" ref-type="bibr"><offsets xml_i="8472" xml_f="8474" txt_i="4093" txt_f="4095">20</offsets></xref><offsets xml_i="8481" xml_f="8483" txt_i="4095" txt_f="4097">).</offsets></p><p><offsets xml_i="8490" xml_f="8673" txt_i="4098" txt_f="4281">α-tocopherol supplementation has previously been demonstrated to be beneficial in increasing the levels of antioxidant enzymes such as SOD and GSH-Px, and of reduced GSH in diabetes (</offsets><xref rid="b21-etm-09-02-0533" ref-type="bibr"><offsets xml_i="8720" xml_f="8722" txt_i="4281" txt_f="4283">21</offsets></xref><offsets xml_i="8729" xml_f="8730" txt_i="4283" txt_f="4284">–</offsets><xref rid="b23-etm-09-02-0533" ref-type="bibr"><offsets xml_i="8777" xml_f="8779" txt_i="4284" txt_f="4286">23</offsets></xref><offsets xml_i="8786" xml_f="8946" txt_i="4286" txt_f="4446">); however, little is known about the effect of adding vitamin E to a flaxseed-enriched diet on oxidative stress and aortic atherosclerotic lesions in diabetes.</offsets></p><p><offsets xml_i="8953" xml_f="9259" txt_i="4447" txt_f="4753">In the present study, the effects of dietary flaxseed, α-tocopherol and their combination were investigated on atherosclerotic progression in diabetic hamsters fed a high-fat diet by examining serum lipid concentrations, oxidative stress markers, aortic cholesterol content and aortic histological aspects.</offsets></p></sec><sec sec-type="materials|methods"><title><offsets xml_i="9310" xml_f="9331" txt_i="4755" txt_f="4776">Materials and methods</offsets></title><sec><title><offsets xml_i="9351" xml_f="9358" txt_i="4777" txt_f="4784">Animals</offsets></title><p><offsets xml_i="9369" xml_f="9891" txt_i="4785" txt_f="5307">A total of 35 male Golden Syrian hamsters were used in the study. The hamsters were purchased from the Cantacuzino National Institute for Research and Development in Microbiology and Immunology (Bucharest, Romania). This study was approved by the Laboratory Animal Care Committee of Grigore T. Popa University of Medicine and Pharmacy (Iaşi, Romania), and the hamsters were maintained in accordance with the general guidelines for the care and use of laboratory animals recommended by the Council of European Communities (</offsets><xref rid="b24-etm-09-02-0533" ref-type="bibr"><offsets xml_i="9938" xml_f="9940" txt_i="5307" txt_f="5309">24</offsets></xref><offsets xml_i="9947" xml_f="9949" txt_i="5309" txt_f="5311">).</offsets></p><p><offsets xml_i="9956" xml_f="10222" txt_i="5312" txt_f="5578">The hamsters were caged singly and kept in standard laboratory conditions with a controlled temperature (20±2°C) and a 12 h light/12 h dark cycle. Diabetes was induced in the hamsters using streptozotocin (STZ; catalog no. S0130; Sigma-Aldrich, St. Louis, MO, USA) (</offsets><xref rid="b25-etm-09-02-0533" ref-type="bibr"><offsets xml_i="10269" xml_f="10271" txt_i="5578" txt_f="5580">25</offsets></xref><offsets xml_i="10278" xml_f="10855" txt_i="5580" txt_f="6154">). STZ, at a dose of 50 mg/kg body weight, freshly solved in citrate buffer (50 mM, pH 4.5), was administered intraperitoneally, as a single dose in the morning, following a night of fasting. Citrate buffer (50 mM) was prepared from sodium citrate and citric acid (S.C. Chemical Company, Iaşi, Romania) dissolved in distilled water, with adjustment of the pH to 4.5. The control group (C) received an equivalent quantity of citrate buffer (50 mM), administered intraperitoneally. All animals having a blood glucose level &gt;126 mg/dl (7 mmol/l) were considered to be diabetic.</offsets></p></sec><sec><title><offsets xml_i="10877" xml_f="10895" txt_i="6156" txt_f="6174">Grouping and diets</offsets></title><p><offsets xml_i="10906" xml_f="10956" txt_i="6175" txt_f="6225">Each hamster received 15 g food/day and tap water </offsets><italic><offsets xml_i="10964" xml_f="10974" txt_i="6225" txt_f="6235">ad libitum</offsets></italic><offsets xml_i="10983" xml_f="11856" txt_i="6235" txt_f="7108">. The animals were randomly divided into a control group (C) and four diabetic groups (DM, DM + flax, DM + E and DM + Flax + E). The hamsters received four different diets for a 20-week period, as follows: i) Groups C and DM received a high-fat diet (40% energy as fat), that was deficient in ALA; ii) the DM + Flax group received a high-fat diet enriched with ground flaxseed (Linum usitatissimum; 15/100 g of food), that was rich in ALA; Flaxseed of the Olin variety was provided by the Department of Phytotechny of the Faculty of Agronomy (Iaşi, Romania). iii) the DM + E group received a high-fat diet enriched with vitamin E (40 mg α-tocopherol/100 g of food; Sigma-Aldrich); and iv) the DM + Flax + E group received a high-fat diet enriched with a combination of flaxseed and vitamin E. All four diets had similar carbohydrate, total fiber, protein and fat contents (</offsets><xref rid="tI-etm-09-02-0533" ref-type="table"><offsets xml_i="11903" xml_f="11910" txt_i="7108" txt_f="7115">Table I</offsets></xref><offsets xml_i="11917" xml_f="11919" txt_i="7115" txt_f="7117">).</offsets></p></sec><sec><title><offsets xml_i="11941" xml_f="11982" txt_i="7119" txt_f="7160">Animal necropsy and processing of samples</offsets></title><p><offsets xml_i="11993" xml_f="12510" txt_i="7161" txt_f="7678">At the end of the experiment, the animals were sacrificed by cardiac puncture under ketamine anesthesia (100 mg/kg body weight). Blood samples were collected without anticoagulant. Aliquots of serum were frozen and kept at −80°C for subsequent analysis. The liver was immediately removed, rinsed with ice-cold saline, placed in a sealed container, homogenized for biochemical analysis and stored at −20°C until analyzed. The aortas were dissected, rinsed with cold saline and preserved in a phosphate buffer (pH 7.2).</offsets></p></sec><sec><title><offsets xml_i="12532" xml_f="12545" txt_i="7680" txt_f="7693">Serum glucose</offsets></title><p><offsets xml_i="12556" xml_f="12781" txt_i="7694" txt_f="7919">Serum glucose was measured by enzymatic colorimetric methods on a Tecan microplate reader (Tecan SunriseTM Touchscreen, Männedorf, Switzerland) using the AD1A716 commercially available kits (Audit Diagnostics, Cork, Ireland).</offsets></p></sec><sec><title><offsets xml_i="12803" xml_f="12822" txt_i="7921" txt_f="7940">Serum lipid profile</offsets></title><p><offsets xml_i="12833" xml_f="13185" txt_i="7941" txt_f="8293">Serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and triglyceride (TG) levels were measured by enzymatic colorimetric methods on a Tecan microplate reader using the AD1A704, AD1A602 and AD1A306 commercially available kits (Audit Diagnostics). Non-HDL-C levels were calculated by subtracting the level of HDL-C from that of TC.</offsets></p></sec><sec><title><offsets xml_i="13207" xml_f="13253" txt_i="8295" txt_f="8341">Evaluation of cholesterol content in the aorta</offsets></title><p><offsets xml_i="13264" xml_f="13685" txt_i="8342" txt_f="8763">The aortas of the hamsters in each group were removed. A section of the aortic arch of each animal was soaked in a 10% (v/v) formal saline solution and was stored on ice prior to being stained and fixed. The remainder of the aorta was soaked in phosphate-buffered saline (PBS) and homogenized for biochemical analysis. The lipid content was extracted by treatment with chloroform and methanol followed by centrifugation (</offsets><xref rid="b26-etm-09-02-0533" ref-type="bibr"><offsets xml_i="13732" xml_f="13734" txt_i="8763" txt_f="8765">26</offsets></xref><offsets xml_i="13741" xml_f="14024" txt_i="8765" txt_f="9048">). The extracted lipid was dissolved in ethanol and measured using a AD1A704 cholesterol assay kit (Audit Diagnostics) utilizing absorbance spectrophotometry (Microlab 300, Vital Scientific, Spankeren, Netherlands) at 500 nm wavelength, and the amount quantified as μg/mg wet tissue.</offsets></p></sec><sec><title><offsets xml_i="14046" xml_f="14076" txt_i="9050" txt_f="9080">Parameters of oxidative stress</offsets></title><p><offsets xml_i="14087" xml_f="14278" txt_i="9081" txt_f="9272">Serum and liver thiobarbituric acid reactive substances (TBARS) are indices of lipid peroxidation and oxidative stress. TBARS were determined using the method described by Phelps and Harris (</offsets><xref rid="b27-etm-09-02-0533" ref-type="bibr"><offsets xml_i="14325" xml_f="14327" txt_i="9272" txt_f="9274">27</offsets></xref><offsets xml_i="14334" xml_f="14434" txt_i="9274" txt_f="9374">). The quantity of the TBARS was measured using a Tecan microplate reader at a wavelength of 540 nm.</offsets></p><p><offsets xml_i="14441" xml_f="14699" txt_i="9375" txt_f="9633">Liver levels of reduced GSH were determined by an enzymatic reaction, based on the oxidation of GSH by 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), in the presence of GSH reductase and methylenetetrahydrofolate reductase, monitored at a wavelength of 405 nm (</offsets><xref rid="b28-etm-09-02-0533" ref-type="bibr"><offsets xml_i="14746" xml_f="14748" txt_i="9633" txt_f="9635">28</offsets></xref><offsets xml_i="14755" xml_f="14843" txt_i="9635" txt_f="9723">). Liver SOD levels were determined using the method described by Minami and Yoshikawa (</offsets><xref rid="b29-etm-09-02-0533" ref-type="bibr"><offsets xml_i="14890" xml_f="14892" txt_i="9723" txt_f="9725">29</offsets></xref><offsets xml_i="14899" xml_f="14901" txt_i="9725" txt_f="9727">).</offsets></p></sec><sec><title><offsets xml_i="14923" xml_f="14955" txt_i="9729" txt_f="9761">Morphological study of the aorta</offsets></title><p><offsets xml_i="14966" xml_f="15603" txt_i="9762" txt_f="10399">For evaluation of aortic atherosclerotic lesions by light microscopy, frozen sections of 10 μm thickness were taken from the region of the proximal aorta. The extent of atherosclerosis was visually assessed after cutting the frozen sections at a size of 8–10 mm, fixing them in formalin, briefly washing them with running tap water for 1–10 mins and rinsing with 60% isopropanol prior to staining the sections with Oil Red O (3 mg/ml Oil Red O in 60% acetone and 40% water; Sigma-Aldrich). The samples were then counterstained with hematoxylin and the samples were examined under a light microscope (Olympus BX40, Olympus, Tokyo, Japan).</offsets></p></sec><sec><title><offsets xml_i="15625" xml_f="15645" txt_i="10401" txt_f="10421">Statistical analysis</offsets></title><p><offsets xml_i="15656" xml_f="15863" txt_i="10422" txt_f="10629">Data are expressed as the mean ± standard deviation (SD). Univariate statistical analysis was performed using the Student’s t-test and Bonferroni’s multiple comparison test (Statistical Software Package SPSS</offsets><sup><offsets xml_i="15868" xml_f="15869" txt_i="10629" txt_f="10630">®</offsets></sup><offsets xml_i="15875" xml_f="15918" txt_i="10630" txt_f="10673">, version 13, SPSS Inc., Chicago, IL, USA).</offsets></p></sec></sec><sec sec-type="results"><title><offsets xml_i="15965" xml_f="15972" txt_i="10676" txt_f="10683">Results</offsets></title><sec><title><offsets xml_i="15992" xml_f="16005" txt_i="10684" txt_f="10697">Serum glucose</offsets></title><p><offsets xml_i="16016" xml_f="16170" txt_i="10698" txt_f="10852">The addition of flaxseed or/and vitamin E to the high-fat diet led to significant reductions of serum glucose levels compared with those in the DM group (</offsets><xref rid="tII-etm-09-02-0533" ref-type="table"><offsets xml_i="16218" xml_f="16226" txt_i="10852" txt_f="10860">Table II</offsets></xref><offsets xml_i="16233" xml_f="16235" txt_i="10860" txt_f="10862">).</offsets></p></sec><sec><title><offsets xml_i="16257" xml_f="16287" txt_i="10864" txt_f="10894">Serum lipid profile parameters</offsets></title><p><offsets xml_i="16298" xml_f="16595" txt_i="10895" txt_f="11192">Diabetes resulted in significant increases in the serum concentrations of TC, TG and non-HDL-C, and a significant reduction of HDL-C concentrations compared with those in the control group. Flaxseed supplementation significantly decreased serum TC and non-HDL-C levels and increased HDL-C levels (</offsets><xref rid="tII-etm-09-02-0533" ref-type="table"><offsets xml_i="16643" xml_f="16651" txt_i="11192" txt_f="11200">Table II</offsets></xref><offsets xml_i="16658" xml_f="16874" txt_i="11200" txt_f="11416">) compared with those in the unsupplemented DM group. The addition of vitamin E to the flaxseed-rich diet significantly decreased TC, non-HDL-C and TG levels but did not improved the HDL-C level in diabetic hamsters.</offsets></p></sec><sec><title><offsets xml_i="16896" xml_f="16928" txt_i="11418" txt_f="11450">Cholesterol content of the aorta</offsets></title><p><offsets xml_i="16939" xml_f="17079" txt_i="11451" txt_f="11591">Aortic cholesterol contents were significantly increased in the DM group fed with a standard diet compared with those in the control group (</offsets><xref rid="tII-etm-09-02-0533" ref-type="table"><offsets xml_i="17127" xml_f="17135" txt_i="11591" txt_f="11599">Table II</offsets></xref><offsets xml_i="17142" xml_f="17279" txt_i="11599" txt_f="11736">). Flaxseed or/and vitamin E supplementation of the diet significantly decreased the aortic cholesterol content in the hamsters with DM (</offsets><xref rid="tII-etm-09-02-0533" ref-type="table"><offsets xml_i="17327" xml_f="17335" txt_i="11736" txt_f="11744">Table II</offsets></xref><offsets xml_i="17342" xml_f="17344" txt_i="11744" txt_f="11746">).</offsets></p></sec><sec><title><offsets xml_i="17366" xml_f="17396" txt_i="11748" txt_f="11778">Parameters of oxidative stress</offsets></title><p><offsets xml_i="17407" xml_f="17443" txt_i="11779" txt_f="11815">The main findings are summarized in </offsets><xref rid="tIII-etm-09-02-0533" ref-type="table"><offsets xml_i="17492" xml_f="17501" txt_i="11815" txt_f="11824">Table III</offsets></xref><offsets xml_i="17508" xml_f="18335" txt_i="11824" txt_f="12651">. Serum and liver TBARS, as indices of lipid peroxidation, were significantly increased in the DM group compared with those in the control group, while the addition of flaxseed or a combination of flaxseed and α-tocopherol to the high-fat diet of the hamsters with DM significantly decreased these two markers compared with those in the unsupplemented DM group. Liver GSH levels were significantly diminished in the DM group compared with those in the control group. Flaxseed, α-tocopherol and their combination added to the high-fat diet significantly increased the liver GSH levels in the diabetic hamsters. The increased in liver GSH content was significantly higher in the DM + Flax + E group compared with that in the DM + Flax group. No significant differences of SOD activity in the liver were identified between groups.</offsets></p></sec><sec><title><offsets xml_i="18357" xml_f="18395" txt_i="12653" txt_f="12691">Histological changes in aortic tissues</offsets></title><sec><title><offsets xml_i="18415" xml_f="18428" txt_i="12692" txt_f="12705">Control group</offsets></title><p><offsets xml_i="18439" xml_f="18563" txt_i="12706" txt_f="12830">The histologic examination of aortal fragments with O-Rd staining revealed discrete thickening of the aortic intimal layer (</offsets><xref rid="f1-etm-09-02-0533" ref-type="fig"><offsets xml_i="18608" xml_f="18615" txt_i="12830" txt_f="12837">Fig. 1A</offsets></xref><offsets xml_i="18622" xml_f="18624" txt_i="12837" txt_f="12839">).</offsets></p></sec><sec><title><offsets xml_i="18646" xml_f="18661" txt_i="12841" txt_f="12856">Diabetic groups</offsets></title><p><offsets xml_i="18672" xml_f="18828" txt_i="12857" txt_f="13013">The histologic examination of aortic fragments with O-Rd staining from diabetic hamsters revealed morphologic changes specific to diabetic macroangiopathy (</offsets><xref rid="f1-etm-09-02-0533" ref-type="fig"><offsets xml_i="18873" xml_f="18880" txt_i="13013" txt_f="13020">Fig. 1B</offsets></xref><offsets xml_i="18887" xml_f="19431" txt_i="13020" txt_f="13564">). Intimal thickening, endothelial discontinuities, lipid drops in the subintimal space, and alterations to the middle layer of the arterial wall were observed. The addition of flaxseed and/or vitamin E to the high-fat diet in diabetic hamsters improved the histological aspects of aortic atherosclerosis described in the diabetic hamsters fed an unsupplemented diet. The aortal tissue in the supplemented groups was characterized by slightly swollen endothelium, with moderate intimal thickening and moderate lipid infiltration of the intima (</offsets><xref rid="f2-etm-09-02-0533" ref-type="fig"><offsets xml_i="19476" xml_f="19482" txt_i="13564" txt_f="13570">Fig. 2</offsets></xref><offsets xml_i="19489" xml_f="19491" txt_i="13570" txt_f="13572">).</offsets></p></sec></sec></sec><sec sec-type="discussion"><title><offsets xml_i="19547" xml_f="19557" txt_i="13576" txt_f="13586">Discussion</offsets></title><p><offsets xml_i="19568" xml_f="19865" txt_i="13587" txt_f="13884">In DM, oxidative stress occurs, primarily due to the increased production of oxygen free radicals and/or a reduction in the antioxidant defense. Numerous studies have demonstrated that an increase in oxidative stress is implicated in the pathogenesis and progression of diabetic vascular lesions (</offsets><xref rid="b1-etm-09-02-0533" ref-type="bibr"><offsets xml_i="19911" xml_f="19912" txt_i="13884" txt_f="13885">1</offsets></xref><offsets xml_i="19919" xml_f="19920" txt_i="13885" txt_f="13886">,</offsets><xref rid="b4-etm-09-02-0533" ref-type="bibr"><offsets xml_i="19966" xml_f="19967" txt_i="13886" txt_f="13887">4</offsets></xref><offsets xml_i="19974" xml_f="19975" txt_i="13887" txt_f="13888">,</offsets><xref rid="b6-etm-09-02-0533" ref-type="bibr"><offsets xml_i="20021" xml_f="20022" txt_i="13888" txt_f="13889">6</offsets></xref><offsets xml_i="20029" xml_f="20031" txt_i="13889" txt_f="13891">).</offsets></p><p><offsets xml_i="20038" xml_f="20149" txt_i="13892" txt_f="14003">In the present study, the antioxidative and antiatherosclerotic effects of supplementation with flaxseed (15 g </offsets><italic><offsets xml_i="20157" xml_f="20176" txt_i="14003" txt_f="14022">Linum usitatissimum</offsets></italic><offsets xml_i="20185" xml_f="20444" txt_i="14022" txt_f="14281">/100 g food), α-tocopherol (40 mg α-tocopherol/100 g food), and their combination were investigated in an animal model that replicates human atherosclerotic lesions. Golden Syrian hamsters appear more predisposed to develop atherosclerotic lesions than rats (</offsets><xref rid="b30-etm-09-02-0533" ref-type="bibr"><offsets xml_i="20491" xml_f="20493" txt_i="14281" txt_f="14283">30</offsets></xref><offsets xml_i="20500" xml_f="20576" txt_i="14283" txt_f="14359">), and present many similarities with the lipoprotein metabolism in humans (</offsets><xref rid="b31-etm-09-02-0533" ref-type="bibr"><offsets xml_i="20623" xml_f="20625" txt_i="14359" txt_f="14361">31</offsets></xref><offsets xml_i="20632" xml_f="20877" txt_i="14361" txt_f="14606">). In hamsters, a 15% flaxseed-supplemented diet is similar in energetic load to the 40 g/day dosage used in human trials. In humans, high doses of 40–50 g flaxseed/day, which corresponds to ~10% of total energy intake have been used in trials (</offsets><xref rid="b32-etm-09-02-0533" ref-type="bibr"><offsets xml_i="20924" xml_f="20926" txt_i="14606" txt_f="14608">32</offsets></xref><offsets xml_i="20933" xml_f="20935" txt_i="14608" txt_f="14610">).</offsets></p><p><offsets xml_i="20942" xml_f="21198" txt_i="14611" txt_f="14867">In the present study, it was hypothesized that adding vitamin E to the flaxseed diet would lead to improved results for oxidative stress and the prevention of atherosclerotic lesions as there is evidence that the consumption of flaxseed reduces vitamin E (</offsets><xref rid="b19-etm-09-02-0533" ref-type="bibr"><offsets xml_i="21245" xml_f="21247" txt_i="14867" txt_f="14869">19</offsets></xref><offsets xml_i="21254" xml_f="21337" txt_i="14869" txt_f="14952">), and only vitamin E supplementation is able to restore the plasma concentration (</offsets><xref rid="b20-etm-09-02-0533" ref-type="bibr"><offsets xml_i="21384" xml_f="21386" txt_i="14952" txt_f="14954">20</offsets></xref><offsets xml_i="21393" xml_f="21395" txt_i="14954" txt_f="14956">).</offsets></p><p><offsets xml_i="21402" xml_f="22052" txt_i="14957" txt_f="15607">The present study demonstrated that all three diets (flaxseed, α-tocopherol or their combination) had an antiatherogenic effect in diabetic hamsters, suggested by the prevention of histological lesions (reduced intimal lipid infiltration and discrete alterations to the middle layer of the arterial wall) and by the decreased aortic cholesterol content in supplemented diabetic hamsters compared with those in the unsupplemented diabetic group. The antiatherogenic mechanism of the diets used in our experiment may be associated with changes in metabolic parameters, particularly in glucose concentrations and the lipid profile, and oxidative stress.</offsets></p><p><offsets xml_i="22059" xml_f="22557" txt_i="15608" txt_f="16106">Flaxseed, α-tocopherol, and the combination of flaxseed and α-tocopherol added to the high-fat diet resulted in similar reductions in serum lipid peroxidation in the diabetic hamsters. Liver lipid peroxidation was significantly diminished by supplementation of the diet by flaxseed alone or in combination with α-tocopherol, but not by α-tocopherol supplementation alone. Moreover, all three diets increased the liver GSH content and the highest concentrations were obtained with the combined diet.</offsets></p><p><offsets xml_i="22564" xml_f="22842" txt_i="16107" txt_f="16385">These results suggest that the higher antioxidant effects of flaxseed plus vitamin E are due to their synergic antioxidant actions. Flaxseed is the richest source of the lignan SDG. SDG isolated from flaxseed has oxygen radical-scavenging properties that have been demonstrated </offsets><italic><offsets xml_i="22850" xml_f="22858" txt_i="16385" txt_f="16393">in vitro</offsets></italic><offsets xml_i="22867" xml_f="22916" txt_i="16393" txt_f="16442"> by direct hydroxyl radical-scavenging activity (</offsets><xref rid="b18-etm-09-02-0533" ref-type="bibr"><offsets xml_i="22963" xml_f="22965" txt_i="16442" txt_f="16444">18</offsets></xref><offsets xml_i="22972" xml_f="23014" txt_i="16444" txt_f="16486">) or by inhibition of lipid peroxidation (</offsets><xref rid="b16-etm-09-02-0533" ref-type="bibr"><offsets xml_i="23061" xml_f="23063" txt_i="16486" txt_f="16488">16</offsets></xref><offsets xml_i="23070" xml_f="23426" txt_i="16488" txt_f="16844">). Vitamin E is known as a major antioxidant in the cellular antioxidant defense system, which acts by interrupting the propagation of free radical chain reactions. The effect of vitamin E against the prooxidant status associated with DM has been demonstrated by the suppression of diabetes-induced increases in ROS and diminishment of lipid peroxidation (</offsets><xref rid="b33-etm-09-02-0533" ref-type="bibr"><offsets xml_i="23473" xml_f="23475" txt_i="16844" txt_f="16846">33</offsets></xref><offsets xml_i="23482" xml_f="23483" txt_i="16846" txt_f="16847">,</offsets><xref rid="b34-etm-09-02-0533" ref-type="bibr"><offsets xml_i="23530" xml_f="23532" txt_i="16847" txt_f="16849">34</offsets></xref><offsets xml_i="23539" xml_f="23646" txt_i="16849" txt_f="16956">). The synergistic effect of flaxseed oil and vitamin E on oxidative stress has also been observed by Deng </offsets><italic><offsets xml_i="23654" xml_f="23659" txt_i="16956" txt_f="16961">et al</offsets></italic><offsets xml_i="23668" xml_f="23670" txt_i="16961" txt_f="16963"> (</offsets><xref rid="b35-etm-09-02-0533" ref-type="bibr"><offsets xml_i="23717" xml_f="23719" txt_i="16963" txt_f="16965">35</offsets></xref><offsets xml_i="23726" xml_f="23768" txt_i="16965" txt_f="17007">) in male Wistar rats fed a high-fat diet.</offsets></p><p><offsets xml_i="23775" xml_f="23820" txt_i="17008" txt_f="17053">Similar to the findings of previous studies (</offsets><xref rid="b36-etm-09-02-0533" ref-type="bibr"><offsets xml_i="23867" xml_f="23869" txt_i="17053" txt_f="17055">36</offsets></xref><offsets xml_i="23876" xml_f="24201" txt_i="17055" txt_f="17380">), the diabetic hamsters had higher serum concentrations of serum glucose, TC, TG and non-HDL-C, and lower HDL-C concentrations compared with the control group. The addition of flaxseed, α-tocopherol or their combination to the high-fat diet reduced serum concentrations of glucose, TC and non-HDL in diabetic male hamsters (</offsets><xref rid="b37-etm-09-02-0533" ref-type="bibr"><offsets xml_i="24248" xml_f="24250" txt_i="17380" txt_f="17382">37</offsets></xref><offsets xml_i="24257" xml_f="24258" txt_i="17382" txt_f="17383">,</offsets><xref rid="b38-etm-09-02-0533" ref-type="bibr"><offsets xml_i="24305" xml_f="24307" txt_i="17383" txt_f="17385">38</offsets></xref><offsets xml_i="24314" xml_f="24423" txt_i="17385" txt_f="17494">). The hypocholesterolemic effects of flaxseed may be attributed to ALA, lignans (SDG) or the fiber content (</offsets><xref rid="b39-etm-09-02-0533" ref-type="bibr"><offsets xml_i="24470" xml_f="24472" txt_i="17494" txt_f="17496">39</offsets></xref><offsets xml_i="24479" xml_f="24515" txt_i="17496" txt_f="17532">). In agreement with other studies (</offsets><xref rid="b40-etm-09-02-0533" ref-type="bibr"><offsets xml_i="24562" xml_f="24564" txt_i="17532" txt_f="17534">40</offsets></xref><offsets xml_i="24571" xml_f="25102" txt_i="17534" txt_f="18065">), vitamin E significantly reduced serum TG levels in diabetic hamsters fed an atherogenic diet. In the present study, the addition of vitamin E alone or in combination with flaxseed to the high-fat diet resulted in lower serum concentrations of TC, non-HDL and TG but failed to correct the HDL-C concentrations in diabetic hamsters. Another study has reported that in hamsters with experimental STZ-induced DM fed high a saturated fat and cholesterol diet, supplementation with α-tocopherol increased TC and did not change HDL-C (</offsets><xref rid="b40-etm-09-02-0533" ref-type="bibr"><offsets xml_i="25149" xml_f="25151" txt_i="18065" txt_f="18067">40</offsets></xref><offsets xml_i="25158" xml_f="25160" txt_i="18067" txt_f="18069">).</offsets></p><p><offsets xml_i="25167" xml_f="25934" txt_i="18070" txt_f="18837">The results of the present study suggest that the antiatherogenic effect of flaxseed, α-tocopherol and their combination added to a high-fat diet in diabetic hamsters is based primarily on the antioxidative role of these components. The improvement of serum glucose and non-HDL were evident and could contribute to the prevention of diabetic macroangiopathy. The antioxidant effect of flaxseed was similar to that of α-tocopherol in diabetic hamsters fed a high-fat diet and the combined diet (Flax + E) did not seem to confer more benefits than flaxseed alone. Moreover, the high dose of ground flaxseed alone may have a better cardioprotective effect than α-tocopherol in diabetic hamsters due to the reduction of TC and non-HDL levels and increase in HDL-C levels.</offsets></p><p><offsets xml_i="25941" xml_f="26171" txt_i="18838" txt_f="19068">Oxidative stress has been proposed as a pathogenic mechanism of diabetic macrovascular complications, and dietary strategies that ameliorate oxidative stress may represent a promising approach to the prevention of atherosclerosis.</offsets></p><p><offsets xml_i="26178" xml_f="26621" txt_i="19069" txt_f="19512">The flaxseed-enriched diet may regulate the generation of reactive oxygen species and the metabolism of glucose and lipids, and could consequently play a role in the prevention of major cardiovascular complications in diabetic states. Ground flaxseed combined with α-tocopherol does not appear to confer a clear advantage compared with flaxseed alone in the reduction of oxidative stress and vascular lesion formation in experimental diabetes.</offsets></p></sec></body><back><ref-list><title>References</title><ref id="b1-etm-09-02-0533"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rains</surname><given-names>JL</given-names></name><name><surname>Jain</surname><given-names>SK</given-names></name></person-group><article-title>Oxidative stress, insulin signaling, and diabetes</article-title><source>Free Radic Biol Med</source><volume>50</volume><fpage>567</fpage><lpage>575</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2010.12.006</pub-id><pub-id pub-id-type="pmid">21163346</pub-id></element-citation></ref><ref id="b2-etm-09-02-0533"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutteridge</surname><given-names>JM</given-names></name><name><surname>Halliwell</surname><given-names>B</given-names></name></person-group><article-title>Antioxidants: Molecules, medicines, and myths</article-title><source>Biochem Biophys Res Commun</source><volume>393</volume><fpage>561</fpage><lpage>564</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2010.02.071</pub-id><pub-id pub-id-type="pmid">20171167</pub-id></element-citation></ref><ref id="b3-etm-09-02-0533"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halliwell</surname><given-names>B</given-names></name></person-group><article-title>The wanderings of a free radical</article-title><source>Free Radic Biol Med</source><volume>46</volume><fpage>531</fpage><lpage>542</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.11.008</pub-id><pub-id pub-id-type="pmid">19111608</pub-id></element-citation></ref><ref id="b4-etm-09-02-0533"><label>4</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Lazo-de-la-Vega-Monroy</surname><given-names>M-L</given-names></name><name><surname>Fernández-Mejía</surname><given-names>C</given-names></name></person-group><article-title>Oxidative stress in diabetes mellitus and the role Of vitamins with antioxidant actions</article-title><source>Oxidative Stress and Chronic Degenerative Diseases - A Role for Antioxidants</source><person-group person-group-type="editor"><name><surname>Morales-González</surname><given-names>JA</given-names></name></person-group><publisher-name>InTech</publisher-name><publisher-loc>Rijeka, Croatia</publisher-loc><fpage>209</fpage><lpage>232</lpage><year>2013</year></element-citation></ref><ref id="b5-etm-09-02-0533"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Likidlilid</surname><given-names>A</given-names></name><name><surname>Patchanans</surname><given-names>N</given-names></name><name><surname>Poldee</surname><given-names>S</given-names></name><name><surname>Peerapatdit</surname><given-names>T</given-names></name></person-group><article-title>Glutathione and glutathione peroxidase in type 1 diabetic patients</article-title><source>J Med Assoc Thai</source><volume>90</volume><fpage>1759</fpage><lpage>1767</lpage><year>2007</year><pub-id pub-id-type="pmid">17957916</pub-id></element-citation></ref><ref id="b6-etm-09-02-0533"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niedowicz</surname><given-names>DM</given-names></name><name><surname>Daleke</surname><given-names>DL</given-names></name></person-group><article-title>The role of oxidative stress in diabetic complications</article-title><source>Cell Biochem Biophys</source><volume>43</volume><fpage>289</fpage><lpage>330</lpage><year>2005</year><pub-id pub-id-type="doi">10.1385/CBB:43:2:289</pub-id><pub-id pub-id-type="pmid">16049352</pub-id></element-citation></ref><ref id="b7-etm-09-02-0533"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>VanderJagt</surname><given-names>DJ</given-names></name><name><surname>Harrison</surname><given-names>JM</given-names></name><name><surname>Ratliff</surname><given-names>DM</given-names></name><name><surname>Hunsaker</surname><given-names>LA</given-names></name><name><surname>Vander Jagt</surname><given-names>DL</given-names></name></person-group><article-title>Oxidative stress indices in IDDM subjects with and without long-term diabetic complications</article-title><source>Clin Biochem</source><volume>34</volume><fpage>265</fpage><lpage>270</lpage><year>2001</year><pub-id pub-id-type="doi">10.1016/S0009-9120(01)00204-1</pub-id><pub-id pub-id-type="pmid">11440725</pub-id></element-citation></ref><ref id="b8-etm-09-02-0533"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>SM</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>de Haan</surname><given-names>JB</given-names></name></person-group><article-title>Oxidative stress and novel antioxidant approaches to reduce diabetic complications</article-title><source>Oxidative Stress and Diseases</source><person-group person-group-type="editor"><name><surname>Lushchak</surname><given-names>V</given-names></name></person-group><publisher-name>InTech</publisher-name><publisher-loc></publisher-loc><fpage>247</fpage><lpage>280</lpage><year>2012</year></element-citation></ref><ref id="b9-etm-09-02-0533"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papageorgiou</surname><given-names>N</given-names></name><name><surname>Tousoulis</surname><given-names>D</given-names></name><name><surname>Katsargyris</surname><given-names>A</given-names></name><etal></etal></person-group><article-title>Antioxidant treatment and endothelial dysfunction: is it time for flavonoids?</article-title><source>Recent Pat Cardiovasc Drug Discov</source><volume>8</volume><fpage>81</fpage><lpage>92</lpage><year>2013</year><pub-id pub-id-type="doi">10.2174/15748901113089990018</pub-id><pub-id pub-id-type="pmid">23952809</pub-id></element-citation></ref><ref id="b10-etm-09-02-0533"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halliwell</surname><given-names>B</given-names></name><name><surname>Rafter</surname><given-names>J</given-names></name><name><surname>Jenner</surname><given-names>A</given-names></name></person-group><article-title>Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not?</article-title><source>Am J Clin Nutr</source><volume>81</volume><fpage>268S</fpage><lpage>276S</lpage><year>2005</year><pub-id pub-id-type="pmid">15640490</pub-id></element-citation></ref><ref id="b11-etm-09-02-0533"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabate</surname><given-names>J</given-names></name><name><surname>Wien</surname><given-names>M</given-names></name></person-group><article-title>Nuts, blood lipids and cardiovascular disease</article-title><source>Asia Pac J Clin Nutr</source><volume>19</volume><fpage>131</fpage><lpage>136</lpage><year>2010</year><pub-id pub-id-type="pmid">20199998</pub-id></element-citation></ref><ref id="b12-etm-09-02-0533"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder</surname><given-names>PC</given-names></name></person-group><article-title>The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability</article-title><source>Mol Nutr Food Res</source><volume>56</volume><fpage>1073</fpage><lpage>1080</lpage><year>2012</year><pub-id pub-id-type="doi">10.1002/mnfr.201100710</pub-id><pub-id pub-id-type="pmid">22760980</pub-id></element-citation></ref><ref id="b13-etm-09-02-0533"><label>13</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Thompson</surname><given-names>LU</given-names></name><name><surname>Cunnane</surname><given-names>SC</given-names></name></person-group><source>Flaxseed in Human Nutrition</source><edition>2nd edition</edition><publisher-name>AOCS Publishing</publisher-name><publisher-loc>Champaign, IL</publisher-loc><year>2003</year><pub-id pub-id-type="doi">10.1201/9781439831915</pub-id></element-citation></ref><ref id="b14-etm-09-02-0533"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloedon</surname><given-names>LT</given-names></name><name><surname>Szapary</surname><given-names>PO</given-names></name></person-group><article-title>Flaxseed and cardiovascular risk</article-title><source>Nutr Rev</source><volume>62</volume><fpage>18</fpage><lpage>27</lpage><year>2004</year><pub-id pub-id-type="doi">10.1111/j.1753-4887.2004.tb00002.x</pub-id><pub-id pub-id-type="pmid">14995053</pub-id></element-citation></ref><ref id="b15-etm-09-02-0533"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><name><surname>Demark-Wahnefried</surname><given-names>W</given-names></name><name><surname>Franco</surname><given-names>OH</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name></person-group><article-title>Meta-analysis of the effects of flaxseed interventions on blood lipids</article-title><source>Am J Clin Nutr</source><volume>90</volume><fpage>288</fpage><lpage>297</lpage><year>2009</year><pub-id pub-id-type="doi">10.3945/ajcn.2009.27469</pub-id><pub-id pub-id-type="pmid">19515737</pub-id></element-citation></ref><ref id="b16-etm-09-02-0533"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>C</given-names></name><name><surname>Yuan</surname><given-names>YV</given-names></name><name><surname>Kitts</surname><given-names>DD</given-names></name></person-group><article-title>Antioxidant activities of the flaxseed lignan secoisolariciresinol diglucoside, its aglycone secoisolariciresinol and the mammalian lignans enterodiol and enterolactone in vitro</article-title><source>Food Chem Toxicol</source><volume>45</volume><fpage>2219</fpage><lpage>2227</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.fct.2007.05.017</pub-id><pub-id pub-id-type="pmid">17624649</pub-id></element-citation></ref><ref id="b17-etm-09-02-0533"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moree</surname><given-names>SS</given-names></name><name><surname>Kavishankar</surname><given-names>GB</given-names></name><name><surname>Rajesha</surname><given-names>J</given-names></name></person-group><article-title>Antidiabetic effect of secoisolariciresinol diglucoside in streptozotocin-induced diabetic rats</article-title><source>Phytomedicine</source><volume>20</volume><fpage>237</fpage><lpage>245</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.phymed.2012.11.011</pub-id><pub-id pub-id-type="pmid">23271000</pub-id></element-citation></ref><ref id="b18-etm-09-02-0533"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>K</given-names></name></person-group><article-title>Antioxidant activity of secoisolariciresinol diglucoside-derived metabolites, secoisolariciresinol, enterodiol, and enterolactone</article-title><source>Int J Angiol</source><volume>9</volume><fpage>220</fpage><lpage>225</lpage><year>2000</year><pub-id pub-id-type="doi">10.1007/BF01623898</pub-id><pub-id pub-id-type="pmid">11062311</pub-id></element-citation></ref><ref id="b19-etm-09-02-0533"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frank</surname><given-names>J</given-names></name><name><surname>Eliasson</surname><given-names>C</given-names></name><name><surname>Leroy-Nivard</surname><given-names>D</given-names></name><etal></etal></person-group><article-title>Dietary secoisolariciresinol diglucoside and its oligomers with 3-hydroxy-3-methyl glutaric acid decrease vitamin E levels in rats</article-title><source>Br J Nutr</source><volume>92</volume><fpage>169</fpage><lpage>176</lpage><year>2004</year><pub-id pub-id-type="doi">10.1079/BJN20041154</pub-id><pub-id pub-id-type="pmid">15231000</pub-id></element-citation></ref><ref id="b20-etm-09-02-0533"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flis</surname><given-names>M</given-names></name><name><surname>Sobotka</surname><given-names>W</given-names></name><name><surname>Antoszkiewicz</surname><given-names>Z</given-names></name><name><surname>Lipiński</surname><given-names>K</given-names></name><name><surname>Zduńczyk</surname><given-names>Z</given-names></name></person-group><article-title>The effect of grain polyphenols and the addition of vitamin E to diets enriched with α-linolenic acid on the antioxidant status of pigs</article-title><source>J Anim Feed Sci</source><volume>19</volume><fpage>539</fpage><lpage>553</lpage><year>2010</year></element-citation></ref><ref id="b21-etm-09-02-0533"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peerapatdit</surname><given-names>T</given-names></name><name><surname>Likidlilid</surname><given-names>A</given-names></name><name><surname>Patchanans</surname><given-names>N</given-names></name><name><surname>Somkasetrin</surname><given-names>A</given-names></name></person-group><article-title>Antioxidant status and lipid peroxidation end products in patients of type 1 diabetes mellitus</article-title><source>J Med Assoc Thai</source><volume>89</volume><issue>Suppl 5</issue><fpage>S141</fpage><lpage>S146</lpage><year>2006</year><pub-id pub-id-type="pmid">17718255</pub-id></element-citation></ref><ref id="b22-etm-09-02-0533"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aksoy</surname><given-names>N</given-names></name><name><surname>Vural</surname><given-names>H</given-names></name><name><surname>Sabuncu</surname><given-names>T</given-names></name><name><surname>Arslanc</surname><given-names>O</given-names></name><name><surname>Aksoy</surname><given-names>S</given-names></name></person-group><article-title>Beneficial effects of vitamins C and E against oxidative stress in diabetic rats</article-title><source>Nutrition Research</source><volume>25</volume><fpage>625</fpage><lpage>630</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.nutres.2005.05.005</pub-id></element-citation></ref><ref id="b23-etm-09-02-0533"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peerapatdit</surname><given-names>T</given-names></name><name><surname>Patchanans</surname><given-names>N</given-names></name><name><surname>Likidlilid</surname><given-names>A</given-names></name><name><surname>Poldee</surname><given-names>S</given-names></name><name><surname>Sriratanasathavorn</surname><given-names>C</given-names></name></person-group><article-title>Plasma lipid peroxidation and antioxidant nutrients in type 2 diabetic patients</article-title><source>J Med Assoc Thai</source><volume>89</volume><issue>Suppl 5</issue><fpage>S147</fpage><lpage>S155</lpage><year>2006</year><pub-id pub-id-type="pmid">17718256</pub-id></element-citation></ref><ref id="b24-etm-09-02-0533"><label>24</label><element-citation publication-type="journal"><article-title>General Guidelines for the Care and Use of Laboratory Animals recommended by the Council of European Communities. Council instructions about the protection of living animals used in scientific investigations</article-title><source>Official Journal of European Communities. Brussels</source><fpage>1</fpage><lpage>18</lpage><year>1986</year></element-citation></ref><ref id="b25-etm-09-02-0533"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Like</surname><given-names>AA</given-names></name><name><surname>Rossini</surname><given-names>AA</given-names></name></person-group><article-title>Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus</article-title><source>Science</source><volume>193</volume><fpage>415</fpage><lpage>417</lpage><year>1976</year><pub-id pub-id-type="doi">10.1126/science.180605</pub-id><pub-id pub-id-type="pmid">180605</pub-id></element-citation></ref><ref id="b26-etm-09-02-0533"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Folch</surname><given-names>J</given-names></name><name><surname>Lees</surname><given-names>M</given-names></name><name><surname>Sloane Stanley</surname><given-names>GH</given-names></name></person-group><article-title>A simple method for the isolation and purification of total lipides from animal tissues</article-title><source>J Biol Chem</source><volume>226</volume><fpage>497</fpage><lpage>509</lpage><year>1957</year><pub-id pub-id-type="pmid">13428781</pub-id></element-citation></ref><ref id="b27-etm-09-02-0533"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelps</surname><given-names>S</given-names></name><name><surname>Harris</surname><given-names>WS</given-names></name></person-group><article-title>Garlic supplementation and lipoprotein oxidation susceptibility</article-title><source>Lipids</source><volume>28</volume><fpage>475</fpage><lpage>477</lpage><year>1993</year><pub-id pub-id-type="doi">10.1007/BF02535949</pub-id><pub-id pub-id-type="pmid">8316057</pub-id></element-citation></ref><ref id="b28-etm-09-02-0533"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tietze</surname><given-names>F</given-names></name></person-group><article-title>Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues</article-title><source>Anal Biochem</source><volume>27</volume><fpage>502</fpage><lpage>522</lpage><year>1969</year><pub-id pub-id-type="doi">10.1016/0003-2697(69)90064-5</pub-id><pub-id pub-id-type="pmid">4388022</pub-id></element-citation></ref><ref id="b29-etm-09-02-0533"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minami</surname><given-names>M</given-names></name><name><surname>Yoshikawa</surname><given-names>H</given-names></name></person-group><article-title>A simplified assay method of superoxide dismutase activity for clinical use</article-title><source>Clin Chim Acta</source><volume>92</volume><fpage>337</fpage><lpage>342</lpage><year>1979</year><pub-id pub-id-type="doi">10.1016/0009-8981(79)90211-0</pub-id><pub-id pub-id-type="pmid">436274</pub-id></element-citation></ref><ref id="b30-etm-09-02-0533"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexaki</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>TA</given-names></name><name><surname>Atallah</surname><given-names>MT</given-names></name><name><surname>Handelman</surname><given-names>G</given-names></name><name><surname>Nicolosi</surname><given-names>RJ</given-names></name></person-group><article-title>Hamsters fed diets high in saturated fat have increased cholesterol accumulation and cytokine production in the aortic arch compared with cholesterol-fed hamsters with moderately elevated plasma non-HDL cholesterol concentrations</article-title><source>J Nutr</source><volume>134</volume><fpage>410</fpage><lpage>415</lpage><year>2004</year><pub-id pub-id-type="pmid">14747681</pub-id></element-citation></ref><ref id="b31-etm-09-02-0533"><label>31</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Simionescu</surname><given-names>MSA</given-names></name></person-group><article-title>Cellular and molecular alterations in diabetes-induced cardiovascular complications studied in an original experimental model</article-title><source>New Insights into Experimental Diabetes</source><person-group person-group-type="editor"><name><surname>Cheta</surname><given-names>DM</given-names></name></person-group><publisher-name>Romanian Academy Publishing House</publisher-name><publisher-loc>Bucharest</publisher-loc><fpage>179</fpage><lpage>209</lpage><year>2002</year></element-citation></ref><ref id="b32-etm-09-02-0533"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mocanu</surname><given-names>V</given-names></name><name><surname>Haliga</surname><given-names>RE</given-names></name><name><surname>Paduraru</surname><given-names>O</given-names></name><etal></etal></person-group><article-title>A diet rich in whole grain flaxseeds has antithrombotic effects without increasing oxidative stress in experimental atherosclerosis</article-title><source>Journal of Biologically Active Products From Nature</source><volume>1</volume><fpage>144</fpage><lpage>159</lpage><year>2011</year><pub-id pub-id-type="doi">10.1080/22311866.2011.10719082</pub-id></element-citation></ref><ref id="b33-etm-09-02-0533"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pazdro</surname><given-names>R</given-names></name><name><surname>Burgess</surname><given-names>JR</given-names></name></person-group><article-title>The role of vitamin E and oxidative stress in diabetes complications</article-title><source>Mech Ageing Dev</source><volume>131</volume><fpage>276</fpage><lpage>286</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.mad.2010.03.005</pub-id><pub-id pub-id-type="pmid">20307566</pub-id></element-citation></ref><ref id="b34-etm-09-02-0533"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munteanu</surname><given-names>A</given-names></name><name><surname>Zingg</surname><given-names>JM</given-names></name><name><surname>Azzi</surname><given-names>A</given-names></name></person-group><article-title>Anti-atherosclerotic effects of vitamin E - myth or reality?</article-title><source>J Cell Mol Med</source><volume>8</volume><fpage>59</fpage><lpage>76</lpage><year>2004</year><pub-id pub-id-type="doi">10.1111/j.1582-4934.2004.tb00260.x</pub-id><pub-id pub-id-type="pmid">15090261</pub-id></element-citation></ref><ref id="b35-etm-09-02-0533"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><etal></etal></person-group><article-title>Effect of flaxseed oil fortified with vitamin E and phytosterols on antioxidant defense capacities and lipids profile in rats</article-title><source>J Food Sci</source><volume>77</volume><fpage>H135</fpage><lpage>140</lpage><year>2012</year><pub-id pub-id-type="doi">10.1111/j.1750-3841.2012.02745.x</pub-id><pub-id pub-id-type="pmid">22671527</pub-id></element-citation></ref><ref id="b36-etm-09-02-0533"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>EA</given-names></name><name><surname>Lightfoot</surname><given-names>SA</given-names></name><name><surname>Hammond</surname><given-names>LJ</given-names></name><etal></etal></person-group><article-title>Flaxseed reduces plasma cholesterol and atherosclerotic lesion formation in ovariectomized Golden Syrian hamsters</article-title><source>Atherosclerosis</source><volume>173</volume><fpage>223</fpage><lpage>229</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2003.12.032</pub-id><pub-id pub-id-type="pmid">15064095</pub-id></element-citation></ref><ref id="b37-etm-09-02-0533"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haliga</surname><given-names>R</given-names></name><name><surname>Mocanu</surname><given-names>V</given-names></name><name><surname>Oboroceanu</surname><given-names>T</given-names></name><name><surname>Stitt</surname><given-names>PA</given-names></name><name><surname>Luca</surname><given-names>VC</given-names></name></person-group><article-title>The effects of dietary flaxseed supplementation on lipid metabolism in streptozotocin-induced diabetic hamsters</article-title><source>Rev Med Chir Soc Med Nat Iasi</source><volume>111</volume><fpage>472</fpage><lpage>476</lpage><year>2007</year><pub-id pub-id-type="pmid">17983187</pub-id></element-citation></ref><ref id="b38-etm-09-02-0533"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soltan</surname><given-names>S</given-names></name><name><surname>Soltan</surname><given-names>AB</given-names></name></person-group><article-title>The Effects of Varieties Sources of Omega-3 Fatty Acids on Diabetes in Rats</article-title><source>Food Nutr Sci</source><volume>3</volume><fpage>1404</fpage><lpage>1412</lpage><year>2012</year><pub-id pub-id-type="doi">10.4236/fns.2012.310184</pub-id></element-citation></ref><ref id="b39-etm-09-02-0533"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prasad</surname><given-names>K</given-names></name></person-group><article-title>Reduction of serum cholesterol and hypercholesterolemic atherosclerosis in rabbits by secoisolariciresinol diglucoside isolated from flaxseed</article-title><source>Circulation</source><volume>99</volume><fpage>1355</fpage><lpage>1362</lpage><year>1999</year><pub-id pub-id-type="doi">10.1161/01.CIR.99.10.1355</pub-id><pub-id pub-id-type="pmid">10077521</pub-id></element-citation></ref><ref id="b40-etm-09-02-0533"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Swefy</surname><given-names>S</given-names></name><name><surname>Schaefer</surname><given-names>EJ</given-names></name><name><surname>Seman</surname><given-names>LJ</given-names></name><etal></etal></person-group><article-title>The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters</article-title><source>Atherosclerosis</source><volume>149</volume><fpage>277</fpage><lpage>286</lpage><year>2000</year><pub-id pub-id-type="doi">10.1016/S0021-9150(99)00331-7</pub-id><pub-id pub-id-type="pmid">10729377</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="f1-etm-09-02-0533" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Images of the aorta. (A) Aortal tissue from the control group fed with a high-fat diet (Oil Red O staining; magnification, ×20). Moderate thickening of the aortic intimal layer (arrows) is present. (B) Aortal tissue from the diabetes mellitus group fed with a high-fat diet (Oil Red O staining; magnification, ×40). A thickened intima, discontinuous endothelium, a few macrophages in the intimal space, lesions in the middle arterial layer, and pronounced infiltration of the intima with lipid vesicles (arrows) is present.</p></caption><graphic xlink:href="ETM-09-02-0533-g00"></graphic></fig><fig id="f2-etm-09-02-0533" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Images of the aorta. (A) Diabetes mellitus (DM) + flaxseed (Flax) group (Oil Red O staining; magnification, ×20). Moderate intimal thickening, endothelium with swollen cells, and moderate infiltration with lipid microvesicles in the intima and internal third of the media (arrows) were observed. (B) DM + Flax + vitamin E (Oil Red O staining; magnification, ×40). The endothelium is slightly swollen with infrequent areas of discontinuity, and a thickened intima with the rare presence of lipid drops (arrow), and moderate structural disorganization of elastic fibers in the middle layer of the vessel wall.</p></caption><graphic xlink:href="ETM-09-02-0533-g01"></graphic></fig><table-wrap id="tI-etm-09-02-0533" orientation="portrait" position="float"><label>Table I</label><caption><p>Composition of the diets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Ingredients</th><th valign="bottom" align="center" rowspan="1" colspan="1">High-fat diet (40% of energy as fat)</th><th valign="bottom" align="center" rowspan="1" colspan="1">High-fat diet supplemented with flaxseed</th><th valign="bottom" align="center" rowspan="1" colspan="1">High-fat diet supplemented with vitamin E</th><th valign="bottom" align="center" rowspan="1" colspan="1">High-fat diet supplemented with flaxseed and vitamin E</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Carbohydrates</td><td valign="top" align="center" rowspan="1" colspan="1">330</td><td valign="top" align="center" rowspan="1" colspan="1">330</td><td valign="top" align="center" rowspan="1" colspan="1">330</td><td valign="top" align="center" rowspan="1" colspan="1">330</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Fiber</td><td valign="top" align="center" rowspan="1" colspan="1">110</td><td valign="top" align="center" rowspan="1" colspan="1">110</td><td valign="top" align="center" rowspan="1" colspan="1">110</td><td valign="top" align="center" rowspan="1" colspan="1">110</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Proteins</td><td valign="top" align="center" rowspan="1" colspan="1">240</td><td valign="top" align="center" rowspan="1" colspan="1">240</td><td valign="top" align="center" rowspan="1" colspan="1">240</td><td valign="top" align="center" rowspan="1" colspan="1">240</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Lipids</td><td valign="top" align="center" rowspan="1" colspan="1">160</td><td valign="top" align="center" rowspan="1" colspan="1">160</td><td valign="top" align="center" rowspan="1" colspan="1">160</td><td valign="top" align="center" rowspan="1" colspan="1">160</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"> Saturated<xref rid="tfn2-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">96</td><td valign="top" align="center" rowspan="1" colspan="1">96</td><td valign="top" align="center" rowspan="1" colspan="1">96</td><td valign="top" align="center" rowspan="1" colspan="1">96</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"> Monounsaturated</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"> Polyunsaturated</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">57</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">n-6 PUFA (sunflower oil)</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">23</td><td valign="top" align="center" rowspan="1" colspan="1">57</td><td valign="top" align="center" rowspan="1" colspan="1">23</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">n-3 PUFA (flaxseed<xref rid="tfn3-etm-09-02-0533" ref-type="table-fn">b</xref>)</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">34</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">34</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Choline</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">3</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Vitamin A (IU)</td><td valign="top" align="center" rowspan="1" colspan="1">200000</td><td valign="top" align="center" rowspan="1" colspan="1">200000</td><td valign="top" align="center" rowspan="1" colspan="1">200000</td><td valign="top" align="center" rowspan="1" colspan="1">200000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Vitamin C</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">1</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Vitamin D (IU)</td><td valign="top" align="center" rowspan="1" colspan="1">10000</td><td valign="top" align="center" rowspan="1" colspan="1">10000</td><td valign="top" align="center" rowspan="1" colspan="1">10000</td><td valign="top" align="center" rowspan="1" colspan="1">10000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Vitamin E</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td><td valign="top" align="center" rowspan="1" colspan="1">0.4</td><td valign="top" align="center" rowspan="1" colspan="1">0.4</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Calcium</td><td valign="top" align="center" rowspan="1" colspan="1">6.2</td><td valign="top" align="center" rowspan="1" colspan="1">6.2</td><td valign="top" align="center" rowspan="1" colspan="1">6.2</td><td valign="top" align="center" rowspan="1" colspan="1">6.2</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Phosphate</td><td valign="top" align="center" rowspan="1" colspan="1">3.9</td><td valign="top" align="center" rowspan="1" colspan="1">3.9</td><td valign="top" align="center" rowspan="1" colspan="1">3.9</td><td valign="top" align="center" rowspan="1" colspan="1">3.9</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Potassium bicarbonate</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">20</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-etm-09-02-0533"><p>Quantities are g/kg diet, unless otherwise indicated. PUFA, polyunsaturated fatty acid.</p></fn><fn id="tfn2-etm-09-02-0533"><label>a</label><p>Hydrogenated coconut oil.</p></fn><fn id="tfn3-etm-09-02-0533"><label>b</label><p>Flaxseeds (<italic>Linum usitatissimum</italic>) of the Olin variety, provided by the Department of Phytotechny, Faculty of Agronomy Iaşi. The composition of the flaxseeds was: 40.2% oil (55.6% linolenic acid) and 19.5% proteins.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tII-etm-09-02-0533" orientation="portrait" position="float"><label>Table II</label><caption><p>Serum glucose, serum lipid profile and aortal cholesterol content in the study groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Parameter</th><th valign="bottom" align="center" rowspan="1" colspan="1">C</th><th valign="bottom" align="center" rowspan="1" colspan="1">DM</th><th valign="bottom" align="center" rowspan="1" colspan="1">DM + Flax</th><th valign="bottom" align="center" rowspan="1" colspan="1">DM + E</th><th valign="bottom" align="center" rowspan="1" colspan="1">DM + Flax + E</th></tr></thead><tbody><tr><td colspan="6" valign="top" align="left" rowspan="1">Serum</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"> Glucose (mg/dl)</td><td valign="top" align="center" rowspan="1" colspan="1">62±7</td><td valign="top" align="center" rowspan="1" colspan="1">362±99<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">139±43<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">143±43<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">163±47<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"> TC (mg/dl)</td><td valign="top" align="center" rowspan="1" colspan="1">232±7</td><td valign="top" align="center" rowspan="1" colspan="1">275±13<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">206±5<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">146±26<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">164±1<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref>–<xref rid="tfn7-etm-09-02-0533" ref-type="table-fn">c</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"> TG (mg/dl)</td><td valign="top" align="center" rowspan="1" colspan="1">217±10</td><td valign="top" align="center" rowspan="1" colspan="1">331±31<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">313±12<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">159±30<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">94±17<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref>–<xref rid="tfn7-etm-09-02-0533" ref-type="table-fn">c</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"> HDL-C (mg/dl)</td><td valign="top" align="center" rowspan="1" colspan="1">78±7</td><td valign="top" align="center" rowspan="1" colspan="1">43±5<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">81±10<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">46±7<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">34±5<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1"> Non-HDL</td><td valign="top" align="center" rowspan="1" colspan="1">154±5</td><td valign="top" align="center" rowspan="1" colspan="1">231±13<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">125±11<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">100±30<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref>,<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">130±12<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td></tr><tr><td valign="bottom" align="left" rowspan="1" colspan="1">Aortal cholesterol (μg/mg wet tissue)</td><td valign="bottom" align="center" rowspan="1" colspan="1">3.6±1.4</td><td valign="bottom" align="center" rowspan="1" colspan="1">4.8±1.7<xref rid="tfn5-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="bottom" align="center" rowspan="1" colspan="1">4.1±1.9<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="bottom" align="center" rowspan="1" colspan="1">4.0±0.9<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="bottom" align="center" rowspan="1" colspan="1">4.2±1.5<xref rid="tfn6-etm-09-02-0533" ref-type="table-fn">b</xref></td></tr></tbody></table><table-wrap-foot><fn id="tfn4-etm-09-02-0533"><p>Values are presented as the means ± standard deviation; n=7 in each group. TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; C, control; DM, diabetes mellitus; Flax, flaxseed; E, vitamin E.</p></fn><fn id="tfn5-etm-09-02-0533"><label>a</label><p>P&lt;0.05 compared with group C.</p></fn><fn id="tfn6-etm-09-02-0533"><label>b</label><p>P&lt;0.05 compared with the DM group.</p></fn><fn id="tfn7-etm-09-02-0533"><label>c</label><p>P&lt;0.05 compared with the DM + Flax group.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tIII-etm-09-02-0533" orientation="portrait" position="float"><label>Table III</label><caption><p>Oxidative stress parameters in the study groups.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom" align="left" rowspan="1" colspan="1">Parameters</th><th valign="bottom" align="center" rowspan="1" colspan="1">C</th><th valign="bottom" align="center" rowspan="1" colspan="1">DM</th><th valign="bottom" align="center" rowspan="1" colspan="1">DM + Flax</th><th valign="bottom" align="center" rowspan="1" colspan="1">DM + E</th><th valign="bottom" align="center" rowspan="1" colspan="1">DM + Flax + E</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Serum TBARS (nmol/ml ser)</td><td valign="top" align="right" rowspan="1" colspan="1">1.6±0.5</td><td valign="top" align="center" rowspan="1" colspan="1">4.3±1.4<xref rid="tfn9-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">1.6±0.5<xref rid="tfn10-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">2.6±1.0<xref rid="tfn9-etm-09-02-0533" ref-type="table-fn">a</xref>,<xref rid="tfn10-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">2.5±0.9<xref rid="tfn10-etm-09-02-0533" ref-type="table-fn">b</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Liver TBARS (nmol/mg prot)</td><td valign="top" align="right" rowspan="1" colspan="1">12.0±1.2</td><td valign="top" align="center" rowspan="1" colspan="1">14.5±2.3<xref rid="tfn9-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">11.9±2.2<xref rid="tfn10-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">15.4±0.9<xref rid="tfn9-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">12.1±1.8<xref rid="tfn10-etm-09-02-0533" ref-type="table-fn">b</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Liver GSH (μM/mg prot)</td><td valign="top" align="right" rowspan="1" colspan="1">17.3±5.6</td><td valign="top" align="center" rowspan="1" colspan="1">10.6±2.1<xref rid="tfn9-etm-09-02-0533" ref-type="table-fn">a</xref></td><td valign="top" align="center" rowspan="1" colspan="1">15.5±3.3<xref rid="tfn10-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">20.7±4.4<xref rid="tfn10-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">33.6±3.9<xref rid="tfn9-etm-09-02-0533" ref-type="table-fn">a</xref>–<xref rid="tfn11-etm-09-02-0533" ref-type="table-fn">c</xref></td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Liver SOD (U/mg prot)</td><td valign="top" align="right" rowspan="1" colspan="1">12.1±0.8</td><td valign="top" align="center" rowspan="1" colspan="1">11.3±0.7</td><td valign="top" align="center" rowspan="1" colspan="1">12.4±1.6</td><td valign="top" align="center" rowspan="1" colspan="1">12.9±0.9<xref rid="tfn10-etm-09-02-0533" ref-type="table-fn">b</xref></td><td valign="top" align="center" rowspan="1" colspan="1">12.5±0.9</td></tr></tbody></table><table-wrap-foot><fn id="tfn8-etm-09-02-0533"><p>Values are means ± standard deviation; n=7 in each group. TBARS, thiobarbituric acid reactive substances; GSH, glutathione; SOD, superoxide dismutase; C, control; DM, diabetes mellitus; Flax, flaxseed; E, vitamin E.</p></fn><fn id="tfn9-etm-09-02-0533"><label>a</label><p>P&lt;0.05 compared with group C.</p></fn><fn id="tfn10-etm-09-02-0533"><label>b</label><p>P&lt;0.05 compared with the DM group.</p></fn><fn id="tfn11-etm-09-02-0533"><label>c</label><p>P&lt;0.05 compared with the DM + Flax group.</p></fn></table-wrap-foot></table-wrap></floats-group></article>